SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login
  • Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis), which is often incurable. Researchers say this study moves them closer to clinical trials for RK-33.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    American Cancer Society Updates Prostate Cancer Screening Guideline Prostate Cancer: Advancements in Screening Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers Virtual Tumor Predict Response to Liver Cancer Immunotherapy Ovarian Cancer Researcher Wins Prestigious Lotus Award Blocking Energy Metabolism May Help Treat Aggressive Pediatric Brain Tumor This new drug could change how we treat one of the deadliest cancers Inherited Long Telomeres May Drive Broad Risk for Lymphoid Cancers
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top